GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TME Pharma NV (XPAR:ALTME) » Definitions » Institutional Ownership

TME Pharma NV (XPAR:ALTME) Institutional Ownership : 0.29% (As of May. 31, 2024)


View and export this data going back to 2016. Start your Free Trial

What is TME Pharma NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TME Pharma NV's institutional ownership is 0.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TME Pharma NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TME Pharma NV's Float Percentage Of Total Shares Outstanding is 0.00%.

TME Pharma NV Institutional Ownership Historical Data

The historical data trend for TME Pharma NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TME Pharma NV Institutional Ownership Chart

TME Pharma NV Historical Data

The historical data trend for TME Pharma NV can be seen below:

2023-02-28 2023-03-31 2023-05-31 2023-06-30 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2024-02-29 2024-03-31
Institutional Ownership 0.72 0.43 0.34 0.34 0.52 0.38 0.70 0.17 0.29 0.29

TME Pharma NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

TME Pharma NV (XPAR:ALTME) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TME Pharma NV (XPAR:ALTME) » Definitions » Institutional Ownership
Comparable Companies
XPAR:ALQGC XPAR:ALMDP XPAR:ALNEV XPAR:ALBPS XPAR:ALPHA XPAR:ALVET XPAR:ALINT XPAR:ALPAT XPAR:ALTHX XPAR:ALNFL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0N6A:Germany
Address
Max-Dohrn-Street 8-10, Berlin, DEU, 10589
Website
https://www.tmepharma.com
TME Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment and focusing on the improvement in the effectiveness of cancer therapies. Its product candidates are; NOX-A12 and NOX-E36 are based on a new class of drug first developed by TME Pharma called Spiegelmers, which offer specific advantages over other drug classes.

TME Pharma NV (XPAR:ALTME) Headlines

No Headlines